POLISCOPE
Back to feed
FEDERALlobbying filing

Cleveland Clinic Foundation Lobbying Report: Q2 2026

Original title: The Cleveland Clinic Foundation → Cleveland Clinic Foundation (2nd Quarter Report 2026)

July 20, 2026

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

This report discloses the financial resources and specific policy areas the Cleveland Clinic Foundation is prioritizing in its interactions with the U.S. House of Representatives and the U.S. Senate.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

The Cleveland Clinic Foundation

The organization is the entity conducting and reporting the lobbying activities to influence federal health policy.

Medicare and Medicaid enrollees

The organization is lobbying on reimbursement and coverage policies that directly impact these programs.

What changed

Last recorded activity July 20, 2026.

What's next

Next step not available in the current record.

Summary

The Cleveland Clinic Foundation reported $130,000 in lobbying expenditures for the second quarter of 2026. The organization focused its advocacy efforts on federal health policy, including Medicare and Medicaid reimbursement, medical education, and various health-related legislative acts.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

How much did the Cleveland Clinic Foundation spend on lobbying in Q2 2026?
The organization reported total lobbying expenses of $130,000 for that period.
Which government bodies were targeted by these lobbying efforts?
The report lists the U.S. House of Representatives and the U.S. Senate as the agencies lobbied.
What specific health issues were covered in this lobbying report?
The report covers a wide range of topics including Medicare/Medicaid reimbursement, graduate medical education, programs, price transparency, and several specific legislative acts like the CHILDReN Act and the Healthy Competition Act.

Why It Matters

This report discloses the financial resources and specific policy areas the Cleveland Clinic Foundation is prioritizing in its interactions with the U.S. House of Representatives and the U.S. Senate.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Broad Advocacy Scope

The organization is simultaneously lobbying on a wide array of disparate issues ranging from quantum computing to specific legislative acts like the CHILDReN Act, indicating a multi-faceted federal policy strategy.

Connected Entities

personCarla DiBlasioLobbyist representing the organization.Map →
organizationU.S. SenateTarget agency for lobbying activities.Map →
organizationThe Cleveland Clinic FoundationThe registrant and client filing the lobbying report.Map →
organizationU.S. House of RepresentativesTarget agency for lobbying activities.Map →
personChad BronsonLobbyist representing the organization.Map →

Sources

Open source document

disclosurespreview.house.gov

Analysis Score

0–100
  • Significance40
    How much this matters to a regular citizen
  • Controversy20
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz15
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record